AAAAAA

   
Results: 1-19 |
Results: 19
A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY ORAL REGIMEN OF 5-FLUOROURACIL (5-FU) PLUS ENILURACIL FOR THE TREATMENT OF PATIENTS WITH TAXANE AND ANTHRACYCLINE-RESISTANT ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS
Authors: RIVERA E CHEVLEN E ECKARDT J KENNEDY MJ SAWHNEY R SUTTON L FRYE D HEDRICK J MCGUIRT C LEVIN J HOHNEKER J WHITE R HORTOBAGYI GN
Citation: E. Rivera et al., A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY ORAL REGIMEN OF 5-FLUOROURACIL (5-FU) PLUS ENILURACIL FOR THE TREATMENT OF PATIENTS WITH TAXANE AND ANTHRACYCLINE-RESISTANT ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS, Annals of oncology, 9, 1998, pp. 70-70
PHASE-I AND PHARMACOKINETIC (PK) TRIAL OF SEQUENCES OF BCNU AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH SOLID NEOPLASMS
Authors: HAMMOND L ECKARDT J KUHN J RIZZO J JOHNSON T VILLALONACALERO M SMITH L DRENGLER R CAMPBELL L VONHOFF D ROWINSKY E
Citation: L. Hammond et al., PHASE-I AND PHARMACOKINETIC (PK) TRIAL OF SEQUENCES OF BCNU AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH SOLID NEOPLASMS, Annals of oncology, 9, 1998, pp. 441-441
A PHASE-I SAFETY AND PHARMACOKINETIC (PK) STUDY OF TEMOZOLOMIDE IN COMBINATION WITH CISPLATIN
Authors: BRITTEN CD ROWINSKY EK AGARWALA SS BAKER SD ECKARDT J DIAB S DUGAN M REIDENBERG P STATKEVICH P MARCO A LOOMBA A FORRAL K KRAYNAK M VONHOFF DD ECKHARDT SG
Citation: Cd. Britten et al., A PHASE-I SAFETY AND PHARMACOKINETIC (PK) STUDY OF TEMOZOLOMIDE IN COMBINATION WITH CISPLATIN, Annals of oncology, 9, 1998, pp. 442-442
A PHASE-I TRIAL OF HUMAN CORTICOTROPIN-RELEASING FACTOR (HCRF) IN PATIENTS WITH PERITUMORAL BRAIN EDEMA
Authors: VILLALONACALERO MA ECKARDT J BURRIS H KRAYNAK M FIELDSJONES S BAZAN C LANCASTER J HANDER T GOLDBLUM R HAMMOND L BARI A DRENGLER R ROTHENBERG M HADOVSKY G VONHOFF DD
Citation: Ma. Villalonacalero et al., A PHASE-I TRIAL OF HUMAN CORTICOTROPIN-RELEASING FACTOR (HCRF) IN PATIENTS WITH PERITUMORAL BRAIN EDEMA, Annals of oncology, 9(1), 1998, pp. 71-77
AN OVERVIEW OF PHASE-II TRIAL RESULTS - IRINOTECAN PLUS CISPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: DEVORE R JOHNSON D CRAWFORD J DIMERY I ECKARDT J ECKHARDT SG
Citation: R. Devore et al., AN OVERVIEW OF PHASE-II TRIAL RESULTS - IRINOTECAN PLUS CISPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Oncology, 12(8), 1998, pp. 79-83
POOLED ANALYSIS OF TOPOTECAN(T) IN THE 2ND-LINE TREATMENT OF PATIENTS(PTS) WITH SENSITIVE SMALL-CELL LUNG-CANCER (SCLC)
Authors: ECKARDT J DEPIERRE A ARDIZZONI A VONPAWEL J FIELDS S
Citation: J. Eckardt et al., POOLED ANALYSIS OF TOPOTECAN(T) IN THE 2ND-LINE TREATMENT OF PATIENTS(PTS) WITH SENSITIVE SMALL-CELL LUNG-CANCER (SCLC), European journal of cancer, 33, 1997, pp. 1041-1041
THE ROLE OF ADJUVANT RADIOTHERAPY IN THE TREATMENT OF RESECTABLE DESMOID TUMORS
Authors: GOY BW LEE SP EILBER F DOREY F ECKARDT J FU YS JUILLARD GJF SELCH MT
Citation: Bw. Goy et al., THE ROLE OF ADJUVANT RADIOTHERAPY IN THE TREATMENT OF RESECTABLE DESMOID TUMORS, International journal of radiation oncology, biology, physics, 39(3), 1997, pp. 659-665
MEASUREMENT AND CALCULATION OF INTENSITY PROFILES IN ELEMENT DISTRIBUTION IMAGES OF NANOTUBES IN THE SCANNING-TRANSMISSION ELECTRON-MICROSCOPE
Authors: KRAMER KH REDLICH P ECKARDT J KOHL H
Citation: Kh. Kramer et al., MEASUREMENT AND CALCULATION OF INTENSITY PROFILES IN ELEMENT DISTRIBUTION IMAGES OF NANOTUBES IN THE SCANNING-TRANSMISSION ELECTRON-MICROSCOPE, European journal of cell biology, 74, 1997, pp. 84-84
SURGICAL-MANAGEMENT OF SOFT-TISSUE SARCOMAS
Authors: EILBER FR ECKARDT J
Citation: Fr. Eilber et J. Eckardt, SURGICAL-MANAGEMENT OF SOFT-TISSUE SARCOMAS, Seminars in oncology, 24(5), 1997, pp. 526-533
A PHASE-I AND BIOAVAILABILITY STUDY OF ORAL TOPOTECAN
Authors: ECKARDT J BURRIS H RIZZO J FIELDS S RODRIGUEZ G DELACRUZ P HODGES S VONHOFF D KUHN J
Citation: J. Eckardt et al., A PHASE-I AND BIOAVAILABILITY STUDY OF ORAL TOPOTECAN, European journal of cancer, 31A, 1995, pp. 927-927
PREOPERATIVE THERAPY FOR SOFT-TISSUE SARCOMA
Authors: EILBER F ECKARDT J ROSEN G FORSCHER C SELCH M FU YS
Citation: F. Eilber et al., PREOPERATIVE THERAPY FOR SOFT-TISSUE SARCOMA, Hematology/oncology clinics of North America, 9(4), 1995, pp. 817-823
PRECLINICAL AND PHASE-I TRIALS OF TOPOISOMERASE-I INHIBITORS
Authors: VONHOFF DD BURRIS HA ECKARDT J ROTHENBERG M FIELDS SM CHEN SF KUHN JG
Citation: Dd. Vonhoff et al., PRECLINICAL AND PHASE-I TRIALS OF TOPOISOMERASE-I INHIBITORS, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000041-190000045
HEAT-SHOCK PROTEINS AND DRUG-RESISTANCE
Authors: FUQUA SAW OESTERREICH S HILSENBECK SG VONHOFF DD ECKARDT J OSBORNE CK
Citation: Saw. Fuqua et al., HEAT-SHOCK PROTEINS AND DRUG-RESISTANCE, Breast cancer research and treatment, 32(1), 1994, pp. 67-71
SYNOVIAL SARCOMA - UNIFORM RESPONSE OF METASTASES TO HIGH-DOSE IFOSFAMIDE
Authors: ROSEN G FORSCHER C LOWENBRAUN S EILBER F ECKARDT J HOLMES C FU YS
Citation: G. Rosen et al., SYNOVIAL SARCOMA - UNIFORM RESPONSE OF METASTASES TO HIGH-DOSE IFOSFAMIDE, Cancer, 73(10), 1994, pp. 2506-2511
DIAGNOSTIC-ACCURACY AND CLINICAL UTILITY OF FINE-NEEDLE ASPIRATION CYTOLOGY IN THE DIAGNOSIS OF CLINICALLY PRIMARY BONE-LESIONS
Authors: LAYFIELD LJ ARMSTRONG K ZALESKI S ECKARDT J
Citation: Lj. Layfield et al., DIAGNOSTIC-ACCURACY AND CLINICAL UTILITY OF FINE-NEEDLE ASPIRATION CYTOLOGY IN THE DIAGNOSIS OF CLINICALLY PRIMARY BONE-LESIONS, Diagnostic cytopathology, 9(2), 1993, pp. 168-173
AUGER MICROPROBE-SURFACE ANALYSIS OF SUB-MU-M NITRIDES AND CARBONITRIDES IN STEEL
Authors: HANTSCHE H SCHMIDT D GOLZE M ZABINSKI A ECKARDT J WIRTH T
Citation: H. Hantsche et al., AUGER MICROPROBE-SURFACE ANALYSIS OF SUB-MU-M NITRIDES AND CARBONITRIDES IN STEEL, Fresenius' journal of analytical chemistry, 346(1-3), 1993, pp. 29-36
PHASE-I CLINICAL-TRIAL OF TAXOTERE ADMINISTERED AS EITHER A 2-HOUR OR6-HOUR INTRAVENOUS-INFUSION
Authors: BURRIS H IRVIN R KUHN J KALTER S SMITH L SHAFFER D FIELDS S WEISS G ECKARDT J RODRIGUEZ G RINALDI D WALL J COOK G SMITH S VREELAND F BAYSSAS M LEBAIL N VONHOFF D
Citation: H. Burris et al., PHASE-I CLINICAL-TRIAL OF TAXOTERE ADMINISTERED AS EITHER A 2-HOUR OR6-HOUR INTRAVENOUS-INFUSION, Journal of clinical oncology, 11(5), 1993, pp. 950-958
PREOPERATIVE CHEMOTHERAPY IN SOFT-TISSUE SARCOMA MANAGEMENT
Authors: ROSEN G EILBER F ECKARDT J HOLMES C FORSCHER CA LOWENBRAUN S SELCH M FU YS
Citation: G. Rosen et al., PREOPERATIVE CHEMOTHERAPY IN SOFT-TISSUE SARCOMA MANAGEMENT, Chirurg, 64(6), 1993, pp. 443-448
SYNOVIAL SARCOMA - A STUDY OF INTENSIVE CHEMOTHERAPY IN 14 PATIENTS WITH LOCALIZED DISEASE
Authors: KAMPE CE ROSEN G EILBER F ECKARDT J LOWENBRAUN S FOSTER J FORSCHER C SELCH M
Citation: Ce. Kampe et al., SYNOVIAL SARCOMA - A STUDY OF INTENSIVE CHEMOTHERAPY IN 14 PATIENTS WITH LOCALIZED DISEASE, Cancer, 72(7), 1993, pp. 2161-2169
Risultati: 1-19 |